Profile data is unavailable for this security.
About the company
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.
- Revenue in HKD (TTM)236.12m
- Net income in HKD-227.29m
- Incorporated2018
- Employees435.00
- LocationAlphamab OncologyNo. 175Fangzhou Road, Suzhou Industrial ParkSuzhou 215125ChinaCHN
- Phone+86 51 262850800
- Websitehttps://www.alphamabonc.com/en/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dawnrays Pharmaceutical (Holdings) Ltd | 1.24bn | 351.37m | 1.77bn | 1.14k | 5.05 | 0.5754 | 3.92 | 1.43 | 0.2338 | 0.2338 | 0.8257 | 2.05 | 0.3156 | 2.31 | 6.37 | 1,085,499.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
SinoMab Bioscience Ltd | 1.47m | -262.03m | 1.90bn | 215.00 | -- | 5.65 | -- | 1,291.21 | -0.2574 | -0.2574 | 0.0015 | 0.3078 | 0.0015 | -- | -- | 6,842.90 | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -11.48 | 0.604 | -- | -- | -- | 14.45 | -- | 106.81 | -- |
Cutia Therapeutics | 148.33m | -2.12bn | 1.99bn | 298.00 | -- | 1.36 | -- | 13.39 | -6.96 | -6.96 | 0.4879 | 4.78 | -- | -- | -- | 497,760.60 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
Frontage Holdings Corp | 2.03bn | 84.43m | 2.10bn | 1.76k | 25.21 | 0.783 | 5.80 | 1.03 | 0.0409 | 0.0409 | 0.9808 | 1.32 | 0.463 | 60.63 | 5.32 | 1,153,999.00 | 1.91 | 4.46 | 2.33 | 5.28 | 30.17 | 34.00 | 4.13 | 9.92 | 1.39 | 4.09 | 0.296 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
Abbisko Cayman Ltd | 20.54m | -465.17m | 2.12bn | 258.00 | -- | 0.9926 | -- | 103.23 | -0.7187 | -0.7187 | 0.0317 | 3.04 | 0.0083 | -- | 1.40 | 79,624.91 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
MicroPort CardioFlow Medtech Corp | 362.38m | -508.23m | 2.29bn | 592.00 | -- | 0.9107 | -- | 6.32 | -0.2151 | -0.2151 | 0.1534 | 1.04 | 0.1205 | 2.78 | 3.67 | 612,126.40 | -16.91 | -17.37 | -18.11 | -22.96 | 2.06 | -1.67 | -140.25 | -180.82 | 9.91 | -11.56 | 0.0293 | -- | 33.94 | -- | -3.77 | -- | -14.16 | -- |
HighTide Therapeutics Inc | 0.00 | -1.01bn | 2.30bn | 66.00 | -- | 2.78 | -- | -- | -2.14 | -2.14 | 0.00 | 1.60 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0229 | -- | -- | -- | -393.76 | -- | -- | -- |
Acotec Scientific Holdings Ltd | 510.72m | 15.61m | 2.35bn | 638.00 | 144.62 | 1.68 | 35.95 | 4.61 | 0.0519 | 0.0519 | 1.70 | 4.46 | 0.3136 | 0.7213 | 3.44 | 800,505.20 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
Peijia Medical Ltd | 475.45m | -423.07m | 2.49bn | 1.04k | -- | 1.01 | -- | 5.23 | -0.623 | -0.623 | 0.6999 | 3.61 | 0.1473 | 0.7773 | 9.51 | 457,167.30 | -13.11 | -34.08 | -14.94 | -36.90 | 73.76 | 71.62 | -88.99 | -448.75 | 6.92 | -- | 0.0886 | -- | 75.86 | -- | 3.75 | -- | -- | -- |
Laekna Inc | 0.00 | -397.51m | 2.63bn | 89.00 | -- | 3.03 | -- | -- | -3.29 | -3.29 | 0.00 | 2.22 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.28 | 0.0655 | -- | -- | -- | 52.81 | -- | -- | -- |
Alphamab Oncology | 235.80m | -226.98m | 2.78bn | 435.00 | -- | 1.54 | -- | 11.79 | -0.236 | -0.236 | 0.2457 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,066.10 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
Golden Throat Holdings Group Co Ltd | 1.04bn | 269.63m | 2.85bn | 869.00 | 10.56 | 1.70 | 9.14 | 2.75 | 0.3647 | 0.3647 | 1.40 | 2.26 | 0.4181 | 4.82 | 1.85 | 1,192,394.00 | 10.88 | 11.00 | 15.85 | 15.63 | 72.57 | 72.79 | 26.02 | 24.67 | 2.48 | 34.74 | 0.21 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
CARsgen Therapeutics Holdings Ltd | 0.00 | -805.99m | 3.29bn | 516.00 | -- | 1.69 | -- | -- | -1.45 | -1.45 | 0.00 | 3.37 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
Biocytogen Pharmaceuticals Beijng Co Ltd | 772.70m | -412.75m | 3.40bn | 1.07k | -- | 4.02 | -- | 4.40 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 724,860.50 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
China Isotope & Radiation Corp | 7.15bn | 399.84m | 3.46bn | 3.11k | 8.66 | 0.6842 | 3.20 | 0.484 | 1.25 | 1.25 | 22.36 | 15.81 | 0.5312 | 4.22 | 1.84 | 2,303,163.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.51bn | 1.93k | 203.91 | 0.8374 | 30.94 | 0.6591 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
Data as of Jun 07 2024. Currency figures normalised to Alphamab Oncology's reporting currency: Hong Kong Dollar HKD
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 09 May 2024 | 23.84m | 2.47% |
Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 16.02m | 1.66% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 11.95m | 1.24% |
First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 8.52m | 0.88% |
BlackRock Fund Advisorsas of 09 May 2024 | 6.49m | 0.67% |
Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.31m | 0.34% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.19m | 0.23% |
BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 1.74m | 0.18% |
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 1.18m | 0.12% |
E Fund Asset Management Co. Ltd.as of 31 Dec 2023 | 968.00k | 0.10% |
More ▼
Data from 31 Dec 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.